Empire Genomics is a clinical molecular diagnostics company. We offer a comprehensive menu of products and services that are used in guiding precise treatments for patients. We work with our clinical, research and biopharmaceutical clients to create innovative and custom solutions to make personalized medicine a reality.
Empire Genomics was founded in 2006 by Dr. Norma J. Nowak from research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The company has developed significant expertise in genomic research, developing custom assays and high-throughput technologies to enable genome-wide analyses.